MedPath

Evaluation of Safety and Performance of the Orbix Breast Lift System

Not Applicable
Withdrawn
Conditions
Breast Ptosis
Registration Number
NCT00774059
Lead Sponsor
Maastricht University Medical Center
Brief Summary

The study is using a new breast lift system to complement a breast-lift operation.

In general there will be recurrence of breast-ptosis after a correcting operation.

With this device we want to minimize this recurrence and provide an "internal bra".

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1.Female subject between 30-50 years of age 2. Subject is referred for mastopexy(breast lifting)due to one of the following reasons:

  • Breast ptosis grade I or II (minimal invasive)
  • Breast ptosis grade I to IV (open procedure)
  • pseudoptosis following breast reduction surgery 3. subject willing to participate as evidenced by signing the written informed consent 4. Minimal invasive: breast cup size <C
Exclusion Criteria
  1. Pregnant or lactating women
  2. history of surgical procedures involving the ribs and rib cage
  3. Osteoporosis
  4. breast implants
  5. breast carcinoma
  6. auto-immune disease -

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Result after using the breast lift system,recurrence of ptosis.one year
Secondary Outcome Measures
NameTimeMethod
complicationsone year

Trial Locations

Locations (1)

Maastricht Univeristy Hospital

🇳🇱

Maastricht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath